Table 2.
PaP score in palliative care populations.
| Development Cohort (n = 519) |
Validation Cohort (n = 451) | Validation Cohort (n = 549) | |
|---|---|---|---|
| Variables | No. Patients (%) | No. Patients (%) | No. Patients (%) |
| Dyspnea | |||
| No | 340 (65.5) | 302 (67.0) | 367 (66.9) |
| Yes | 179 (34.5) | 149 (33.0) | 182 (33.1) |
| Anorexia | |||
| No | 191 (36.8) | 181 (40.1) | 207 (37.7) |
| Yes | 328 (63.2) | 270 (59.9) | 342 (62.3) |
| KPS | |||
| ≥50 | 248 (17.8) | 140 (31.0) | 79 (14.4) |
| 30–40 | 217 (41.8) | 260 (57.6) | 356 (64.8) |
| 10–20 | 54 (10.4) | 51 (11.3) | 114 (20.8) |
| CPS (weeks) | |||
| >12 | 69 (13.3) | 49 (10.9) | 46 (8.4) |
| 11–12 | 51 (9.8) | 47 (10.4) | 52 (9.5) |
| 9–10 | 41 (7.9) | 32 (7.1) | 40 (7.3) |
| 7–8 | 77 (14.8) | 64 (14.2) | 86 (15.6) |
| 5–6 | 74 (14.3) | 65 (14.4) | 78 (14.2) |
| 3–4 | 109 (21.0) | 114 (25.3) | 134 (24.4) |
| 1–2 | 81 (15.6) | 80 (17.7) | 113 (20.6) |
| Total WBC (cells/mm3) | |||
| Normal (4800–8500) | 256 (49.3) | 253 (56.1) | 252 (45.9) |
| High (8501–11000) | 120 (23.1) | 107 (23.7) | 101 (18.4) |
| Very high (>11000) | 143 (27.6) | 91 (20.2) | 196 (35.7) |
| Lymphocyte rate (%) | |||
| Normal (20.0–40.0) | 150 (28.9) | 162 (35.9) | 114 (20.8) |
| Low (12.0–19.9) | 198 (38.2) | 180 (39.9) | 148 (27.0) |
| Very low (0–11.9) | 171 (32.9) | 109 (24.2) | 287 (52.2) |
| Risk groups | |||
| A (total score 0.0–5.5) | 178 (34.3) | 127 (28.2) | 181 (33.0) |
| B (total score 5.6–11.0) | 205 (39.5) | 206 (45.7) | 222 (40.4) |
| C (total score 11.1–17.5) | 136 (26.2) | 118 (26.1) | 146 (26.6) |
KPS: Karnofsky Performance Status; CPS: Clinical Prediction of Survival; Total WBC: Total White Blood Count.